جست‌وجوی استاد و پژوهشگر

Peter Kassonمشاهده پروفایل

استاد

• Biophysical Chemistry
• Computational Chemistry
• Membrane Biophysics
• +۶ مورد دیگر

Peter Kasson is a Professor in the School of Chemistry & Biochemistry at the Georgia Institute of Technology , where he leads the Kasson Laboratory . The lab operates internationally, with active collaborations and postdoctoral positions based in both the United States and Sweden. Education PhD/MD via the Stanford University MSTP program Research Interests The Kasson group integrates biophysical experiments with large-scale molecular simulations and machine learning to dissect how enveloped viruses—such as Influenza , SARS-CoV-2 , and Zika —enter host cells. By combining single-virus spectroscopy , cryo-electron microscopy , and computational modeling , the team explores: Membrane fusion mechanisms and lipid determinants that control viral entry. Drug-resistance evolution in viral proteins and antibiotic uptake in bacteria. Methods development for adaptive ensemble simulations (e.g., gmxapi , ProGuide ). Global health applications, including pandemic-risk prediction and vaccine design. The group also contributes to public science initiatives such as Folding@Home , leveraging citizen computing to study viral dynamics worldwide. Recent Research Trends Over the past five years, Prof. Kasson’s publications have converged on coronavirus and influenza entry kinetics, membrane lipid control of fusion, and integrative structural biology of viral proteins. A notable 2025 suite of studies clarifies how sphingomyelin , caveolin-1 , and lipid curvature modulate viral infection, while computational work refines experimental data via advanced statistical models. Awards & Honors 2021 Pinn Scholar – recognition of outstanding research contributions. Training & Funding The Kasson Lab is currently supported by NIGMS R01 grants targeting heterogeneous conformational ensembles in viral proteins. The group actively recruits PhD students through Georgia Tech programs (Biomedical Engineering, Chemistry & Biochemistry, Bioengineering, Quantitative Biosciences) as well as postdoctoral fellows in both experimental and computational tracks. Labs & Teams Research is conducted in the Kasson Laboratory located in IBB 1305 on the Georgia Tech campus, with satellite activities at Uppsala University in Sweden. The team comprises a diverse, international cohort of PhD students, postdocs, and undergraduates working together on global infectious-disease challenges.

Adriano Aguzziمشاهده پروفایل

استاد

• Neurodegeneration
• Prion Diseases
• Neuroimmunology
• +۲ مورد دیگر

Adriano Aguzzi is a Full Professor of Neuropathology at the University of Zurich and Director of the Institute of Neuropathology at the University Hospital Zurich. He has led the National Reference Center for Prion Diseases since 1995. His primary affiliations include the Faculty of Medicine and the Faculty of Mathematics and Natural Sciences, where he investigates neurodegeneration, prion biology, and neuroimmune interactions. His research focuses on: Molecular mechanisms of prion diseases and protein misfolding Neuroinflammation and microglial dynamics Transgenic models for neurodegeneration High-throughput therapeutic screening using CRISPR and omics technologies Recent publications (2022–2025) emphasize neuropathology of aging, prion transmission mechanisms, glial cell functions, and innovative therapeutic delivery systems. Honors include memberships in: EMBO Royal College of Physicians (FRCP) Austrian Academy of Sciences German Academy of Natural Scientists Leopoldina He directs the Institute of Neuropathology and the National Prion Disease Center, coordinating interdisciplinary teams for clinical diagnostics and experimental neuropathology.

Alexander Gowمشاهده پروفایل

استاد

• Neurogenetics
• Neurodegenerative Diseases
• Myelin Biology
• +۴ مورد دیگر

Alexander Gow is Professor of Molecular Medicine and Genetics, Pediatrics, and Neurology at Wayne State University, focusing on neurodegenerative diseases and white matter disorders. His research spans multiple disciplines including molecular genetics, neuroscience, and computational biology. PhD from University of Queensland (1990) Charles H. Gershenson Distinguished Fellow Associate Director, Center for Molecular Medicine and Genetics His research explores: Protein misfolding in Pelizaeus-Merzbacher disease Unfolded Protein Response (UPR) in neurodegeneration Claudin-11 protein's role in myelin and auditory function Drug development pipelines for neurodegenerative disorders Mouse models for white matter diseases Computational modeling of neural systems Recent publications focus on myelin integrity analysis, neurodegenerative modeling, and AI applications in biomedical research. Notable collaborations include researchers from Biomedical Engineering, Psychiatry, and Otolaryngology departments at Wayne State University. Scientific awards include multiple Research Excellence Awards from Wayne State University (2004, 2009, 2013) and the Charles H. Gershenson Distinguished Fellowship (2010).

• Neuromuscular Diseases
• Respiratory Medicine
• Neurology
• +۱ مورد دیگر

Michael A Gaytant is an Assistant Professor at Utrecht University Medical Center, focusing on neuromuscular diseases and respiratory medicine. He has contributed to clinical research in amyotrophic lateral sclerosis (ALS), nemaline myopathy, and spinal muscular atrophy, particularly in respiratory support strategies. Research Interests: Clinical applications in neuromuscular disorders, non-invasive ventilation, mechanical insufflation-exsufflation, and neurotechnology. Collaborations: Worked with multidisciplinary teams in studies involving ALS and centronuclear myopathy patients. Recent Publications emphasize respiratory management trends in neuromuscular diseases, with a focus on ALS and spinal muscular atrophy. These studies span clinical trials, longitudinal analyses, and cross-sectional research.

Alia A. Matysikمشاهده پروفایل

استاد

• Alzheimer's Disease
• Magnetic Resonance Imaging
• Zebrafish Neurobiology
• +۳ مورد دیگر

Prof. Dr. Alia A. Matysik is a leading academic with dual affiliations: as a Group Leader at Leipzig University's Institute for Medical Physics and Biophysics (since 2014) and as a tenured Assistant Professor at Leiden University's Leiden Institute of Chemistry (since 2007). Her research bridges neurodegenerative diseases and environmental toxicology, leveraging ultra-high-field magnetic resonance imaging (μMRI) and spectroscopy to study Alzheimer's disease mechanisms, zebrafish metabolic pathways, and nanoplastics toxicity. Research Focus: Her work dissects gender-specific Alzheimer's progression, circadian disruptions in neurodegeneration, metabolic profiling in zebrafish models, and environmental toxin impacts. She pioneers non-invasive MRI techniques for in vivo brain imaging and develops NMR-based toxicology assays. Key collaborations span Europe (Paul Flechsig Institute, University of Leiden) and the US (Florida International University). Honors & Funding: Recipient of 10+ awards, including the Alzheimer Forschung Initiative Grant (2013), C.J. Kok Prize (2004), and JSPS Fellowship (1996). Secured major grants from NWO, ISAO, and CMSB for projects on Alzheimer's biomarkers and phenotypic engineering. Advising & Labs: Supervises doctoral/master's students in neuroimaging and metabolomics. Leads interdisciplinary teams at Leipzig and collaborates on EU-wide consortia. Her lab develops cutting-edge μMRI protocols for transgenic models.

Jalees Rehmanمشاهده پروفایل

استاد

• Cardiology
• Inflammation
• Lung Infection
• +۵ مورد دیگر

Dr. Jalees Rehman serves as Professor of Medicine and Pharmacology and Head of the Department of Biochemistry and Molecular Genetics at the University of Illinois Chicago College of Medicine. His leadership spans institutional administration and cutting-edge biomedical research focused on vascular injury mechanisms. His research expertise encompasses: Organ-specific blood vessel vulnerability (particularly lung vasculature in severe infections) Modulation of inflammatory responses to prevent tissue damage Stem cell-mediated tissue regeneration pathways Machine learning applications for gene regulation analysis in injury/repair processes Recent research trends demonstrate strong integration of computational approaches with vascular biology, particularly in understanding: COVID-19-related vascular complications Post-viral neurological disorders Cancer-associated vascular dysfunction No scientific awards are documented in available sources. His laboratory actively trains graduate students through the Graduate Education in Biomedical Sciences (GEMS) program, particularly within the Cell Biology and Regenerative Medicine concentration. Research is supported by NIH funding within the top-ranked Pharmacology and Regenerative Medicine department. Dr. Rehman's laboratory focuses on vascular injury mechanisms in bacterial/viral infections, utilizing both experimental models and computational tools to identify therapeutic targets for tissue protection and regeneration.

Mamta Amruteمشاهده پروفایل

دانشیار

• Molecular motor proteins
• Hypertrophic cardiomyopathy
• Single molecule biophysics
• +۵ مورد دیگر

Dr. Mamta Amrute is an Associate Professor and Principal Investigator at the Institute of Molecular and Cell Physiology, Hannover Medical School (MHH), where she has led her research group since 2017. Her academic journey includes a PhD from MHH (2003-2006), postdoctoral research at MHH (2012-2016), and at the prestigious Medical Research Council-Laboratory of Molecular Biology in Cambridge, UK (2008-2011). Her research program focuses on single-molecule biophysics of molecular motor proteins , with particular emphasis on understanding how mutations in cardiac myosin lead to hypertrophic cardiomyopathy (HCM), a condition affecting approximately 1 in 200 individuals worldwide. The lab employs advanced techniques including Total Internal Reflection Fluorescence Microscopy, optical trapping, and zero-mode waveguides to investigate fundamental motor protein mechanisms. Analysis of recent publications reveals three major research trajectories: 1) Detailed characterization of cardiac and skeletal myosin isoforms at the single-molecule level, 2) Investigation of epigenetic regulation in muscle physiology and atrophy, and 3) Development of computational tools for biochemical research. This work has significant implications for understanding and potentially treating heart disease and muscle wasting conditions. Dr. Amrute's research is supported by multiple funding sources including the Deutsche Forschungsgemeinschaft (DFG), Fritz Thyssen Foundation, and MHH's early career research grant program (HilF). She supervises a diverse team of doctoral students and postdoctoral researchers, providing training in advanced biophysical techniques. The Amrute-Nayak Research Group maintains an extensive international collaboration network spanning institutions in the UK, USA, Japan, Italy, Sweden, and Australia, facilitating cross-disciplinary approaches to studying molecular motors and muscle diseases. Her work bridges fundamental biophysics with clinical applications in cardiology and muscle physiology.

Espen Spangenburgمشاهده پروفایل

استاد

• Skeletal Muscle Physiology
• Endocrine Regulation
• Metabolic Function
• +۵ مورد دیگر

Dr. Espen Spangenburg is a Professor and Chair in the Department of Anatomy and Cell Biology at the Brody School of Medicine, East Carolina University, where he also holds an appointment at the East Carolina Diabetes and Obesity Institute (ECDOI). Previously, he served as an Associate Professor in the Department of Physiology at the same institution (2015-2021), and held faculty positions at the University of Maryland (2006-2015) and UC Davis (2003-2006). Dr. Spangenburg's research program focuses on understanding the endocrine-based regulation of physiological and metabolic function of skeletal muscle. His lab employs an integrative experimental approach, using cell culture and animal models to define mechanisms that they then translate to human physiology. They have developed skeletal muscle-specific inducible BRCA1 and ER-alpha knock out mice and techniques to ablate these genes in cultured human myotubes. The lab has pioneered methods to measure force, mitochondrial function, deliver cDNA, and image organelles in single muscle fibers. His publication record includes over 120 peer-reviewed articles with an h-index of 52 and more than 8,221 total citations, including 19 papers cited over 100 times. His most recent work continues to explore skeletal muscle metabolism, mitochondrial function, and endocrine regulation, with publications in high-impact journals including Cell Metabolism, Diabetes, and Circulation. Selected Awards: 2014 Leda Amick Wilson UMD Mentor of the Year Award 2011 Best Paper Award UMD School of Public Health Research Interaction Day 2010 Virginia Tech HNFE Outstanding Alumnus Award 2008-2014 NIH Loan Repayment Grant Recipient Dr. Spangenburg serves on multiple editorial boards including American Journal of Physiology: Cell Physiology and Journal of Applied Physiology. He has been an active NIH study section member since 2015 and has received continuous research funding from NIH and the American Diabetes Association for his work on skeletal muscle function and metabolism. His lab maintains an active research program investigating the role of BRCA1 and estrogen receptor signaling in skeletal muscle function, with current projects examining how these pathways regulate mitochondrial function and protect against metabolic disease.

Henry W. Green, IIIمشاهده پروفایل

دانشیار

• Veterinary Cardiology
• Interventional Cardiology
• Cardiac Pacing
• +۲ مورد دیگر

Henry W. Green, III serves as Associate Dean for Organizational Health and Mentorship and Associate Professor of Veterinary Cardiology at Louisiana State University's School of Veterinary Medicine, where he leads in both academic administration and clinical cardiology. His educational foundation includes: BS from University of New Orleans (1994) DVM from Louisiana State University (1999) Dr. Green's research explores interventional cardiology (catheter-based heart procedures), cardiac pacing (implantable rhythm devices), muscle atrophy in cardiac contexts, and cardiomyopathies . His work advances minimally invasive treatments for animal heart conditions through clinical innovation and physiological investigation. As an educator, he teaches clinical cardiology, cardiac physiology, and pharmacology while mentoring students in professional development. His board certification as a Diplomate of the American College of Veterinary Internal Medicine (Cardiology) underscores his specialized expertise. Administratively, he drives faculty wellness and mentorship initiatives as Associate Dean, integrating clinical excellence with organizational leadership to strengthen veterinary medical education.

• Genome Editing
• CRISPR Technologies
• Neuromuscular Diseases
• +۶ مورد دیگر

Christiano Alves, PhD is an Assistant Professor in the Department of Pathology at the University of Pittsburgh, specifically within the Division of Experimental Pathology. His research program integrates cutting-edge genome editing technologies with applied physiology to develop novel therapies for neuromuscular and metabolic diseases. Dr. Alves received his BS and PhD from the University of Sao Paulo, Brazil, completing his doctoral studies in 2017. He then completed postdoctoral training at Harvard Medical School and Massachusetts General Hospital, where he worked at the Joslin Diabetes Center on projects related to exercise and metabolism, and later at the Center for Genomic Medicine focusing on neuromuscular diseases and CRISPR technologies under the mentorship of Dr. Benjamin Kleinstiver. His research interests lie at the intersection of genome editing and applied physiology, with a specific focus on developing treatments for neurodegenerative conditions including Amyotrophic Lateral Sclerosis (ALS) and spinal muscular atrophy (SMA). The Alves Lab leverages expertise in molecular metabolism and muscle biology to optimize genome editing approaches for therapeutic applications. Genome Editing and CRISPR Technologies Neuromuscular Diseases Neurodegenerative Disorders Metabolic Diseases Therapeutic Development Translational Medicine Dr. Alves has established an active research program with multiple publications in high-impact journals, focusing on the development and optimization of base editing technologies for treating genetic disorders. His work demonstrates a strong trajectory in advancing genome editing approaches toward clinical applications for severe diseases. As a recently appointed independent investigator, Dr. Alves is building a research team focused on pushing the boundaries of genome editing therapeutics. His lab combines physiological expertise with advanced gene editing techniques to address significant unmet medical needs in neurodegenerative conditions. The Alves Lab is actively seeking motivated students and postdoctoral researchers interested in genome editing, neuromuscular diseases, and translational research. Prospective trainees should have a strong foundation in molecular biology and an interest in developing innovative therapeutic approaches for severe diseases.

Emil Ylikallioمشاهده پروفایل

پژوهشگر

• Neurology
• Neurogenetics
• Motor Neuron Disease
• +۳ مورد دیگر

Emil Ylikallio is an Associated Clinical Researcher at the Medical Neurogenetics Lab within the Stem Cells and Metabolism Research Program (STEMM) at the University of Helsinki. He concurrently serves as a Clinical Neurologist and heads the Rare Neurological Diseases Program at HUS Helsinki University Hospital. His academic appointments include positions in the Department of Neurosciences and Center of Excellence in Stem Cell Metabolism, where he supervises doctoral candidates in Clinical Research and Biomedicine. Education includes: Licentiate of Medicine (Mechanisms and Effects of Mitochondrial DNA Instability) - University of Helsinki, Faculty of Medicine (2011) Master of Medical Sciences - University of Helsinki, Faculty of Medicine (2010) Research focuses on molecular mechanisms of neurodegenerative conditions, with particular expertise in: Motor neuron disease pathogenesis and metabolic alterations Hereditary peripheral neuropathies including Charcot-Marie-Tooth variants Mitochondrial dysfunction in neurological disorders Stem cell models of neuromuscular diseases His work bridges clinical neurology with basic research in neurogenetics. Publication analysis reveals strong focus on: Genetic basis of peripheral neuropathies and motor neuron disorders Metabolic dysregulation in neuromuscular conditions Stem cell modeling of neurological diseases Identification of novel biomarkers and therapeutic targets Research employs cutting-edge techniques including cellular reprogramming, CRISPR modification, and multi-omics approaches. Current research leadership includes: Principal Investigator for 'Axon degeneration: new mechanisms, biomarkers and treatment' project (Funded by Academy of Finland) Project lead for Swedish Masonic Order-funded research (2025-2027) Supervises doctoral candidates and serves on national/international committees. Leads research activities through the Medical Neurogenetics Lab and collaborates extensively with HUS Neurocenter. Team focuses on translational research bridging molecular discoveries with clinical neurology applications.

Hans-Jürgen Gdyniaمشاهده پروفایل

مدرس

• Neurology
• Geriatrics
• Neurorehabilitation
• +۳ مورد دیگر

Hans-Jürgen Gdynia is a Lecturer at the Chair of Social and Health Education within the Faculty of Philosophy and Education at the Catholic University of Eichstätt-Ingolstadt . He serves as Chief Physician of Neurology and Head of Neurology at the m&i Enzensberg Clinic Group , with additional qualifications in Geriatrics and Physical Therapy/Balneology . His career spans institutions like the University Hospital Ulm and Helios Klinik Kipfenberg . Education: MD (magna cum laude, 2004) from Friedrich Schiller University Jena , and a Master of Health Business Administration (2021-2023) from Friedrich-Alexander University Erlangen-Nuremberg . Research Interests focus on neurorehabilitation , particularly for stroke and traumatic brain injury patients, and neurodegenerative disorders including Parkinson’s disease and amyotrophic lateral sclerosis (ALS). His work explores carotid artery dissection pathogenesis, ICU-acquired weakness rehabilitation, and spinal meningioma outcomes. Publications span journals like Neurocritical Care and Acta Neurologica Scandinavica . Professional Leadership includes heading the Neurorehabilitation Working Group and the Study Center for the OptiNIV study (funded by the Innovation Committee of the Federal Joint Committee with €5.3M over 4 years). He is a board member of the Working Group for Rehabilitation of Stroke Patients in Bavaria. Memberships: German Society of Neurology, German Society for Clinical Neurophysiology, Treat-NMD Muscular Dystrophy Network, German Society for Muscular Diseases, and the Working Group for Rehabilitation of Stroke Patients in Bavaria.

Barrington G. Burnettمشاهده پروفایل

دانشیار

• Protein degradation
• Ubiquitin signaling
• Neurodegeneration
• +۵ مورد دیگر

Barrington G. Burnett is an Associate Professor and Vice Chair for Research in the Department of Anatomy, Physiology and Genetics at the Uniformed Services University of the Health Sciences School of Medicine in Bethesda, MD. His research program focuses on understanding protein degradation pathways and their role in neurodegenerative diseases, with particular emphasis on spinal muscular atrophy (SMA). Dr. Burnett received his educational training at prestigious institutions: PhD in Pharmacology from the University of Pennsylvania (2005) MA in Chemistry from Temple University (2000) BS in Chemistry from Temple University (1998) Dr. Burnett's research centers on protein degradation pathways, ubiquitin signaling, and their implications in neurodegenerative conditions. His laboratory investigates how disruptions in these pathways contribute to diseases like spinal muscular atrophy, with recent work expanding into traumatic brain injury and neuroinflammation. His team employs a multidisciplinary approach combining molecular biology, cell culture systems, and animal models to identify therapeutic targets for neurological disorders. Analysis of Dr. Burnett's recent publications reveals a strong focus on spinal muscular atrophy mechanisms and potential treatments. His work spans multiple aspects of SMA pathology including motor neuron degeneration, muscle development defects, cardiac complications, and neuroinflammatory components. A significant portion of his research investigates SMN protein stability, degradation pathways, and strategies to increase functional SMN protein levels through pharmacological interventions. Dr. Burnett has received several prestigious awards recognizing his contributions to neuroscience and education: Outstanding Biomedical Educator Award (2021) Cinda Helke Award for Excellence in Graduate Student Advocacy (2019) Dean's Impact Award recognizing excellence in research Emerging Investigator Award from FightSMA & The Gwendolyn Strong Foundation (2014) As Vice Chair for Research, Dr. Burnett oversees the research enterprise in his department while maintaining an active NIH-funded laboratory. His research group has made significant contributions to understanding the molecular mechanisms underlying spinal muscular atrophy, particularly regarding SMN protein regulation and the role of ubiquitin-proteasome system. He has mentored numerous graduate students and postdoctoral fellows, with recognition for his excellence in student advocacy. Dr. Burnett collaborates extensively with researchers across multiple institutions, as evidenced by his co-authorship on numerous multi-institutional studies. Dr. Burnett leads a research laboratory focused on protein degradation pathways in neurodegeneration. His team employs cutting-edge techniques in molecular biology, cell culture, and animal modeling to investigate disease mechanisms and identify therapeutic targets. Recent work has expanded to include investigations of neuroinflammation and the role of microglia in SMA pathology, as well as cardiac complications associated with the disease.

Alexander Y. Shinمشاهده پروفایل

استاد

• Hand Surgery
• Brachial Plexus Injuries
• Peripheral Nerve Injuries
• +۸ مورد دیگر

Alexander Y. Shin, M.D. is a distinguished Professor of Neurosurgery, Orthopedics, and Regenerative Medicine at Mayo Clinic College of Medicine and Science, where he serves as Chair of the Division of Hand Surgery in the Department of Orthopedic Surgery. He holds joint appointments as Consultant in the Department of Orthopedic Surgery and the Department of Pediatric and Adolescent Medicine at Mayo Clinic in Rochester, Minnesota. Dr. Shin directs the Neural Regenerative Research Laboratory, previously known as the Microvascular Research Laboratory, which he has led since 2017. Dr. Shin's research spans both clinical and basic science domains, with a primary focus on enhancing peripheral nerve regeneration. His work investigates stem cells, exosomes, surgical angiogenesis, and modulation of the local immune response to improve outcomes in nerve reconstruction. Clinically, he specializes in complex upper extremity reconstruction, particularly traumatic brachial plexus injuries across all age groups, peripheral nerve injuries, and complex wrist fractures and reconstructions. Analysis of Dr. Shin's extensive publication record (over 559 research outputs) reveals a strong focus on translational research that bridges clinical needs with laboratory investigations. His work shows consistent emphasis on improving surgical techniques for nerve reconstruction, optimizing outcomes in brachial plexus injuries, and advancing understanding of nerve regeneration mechanisms. Recent publications demonstrate continued innovation in areas including diagnostic neuromuscular ultrasonography, surgical restoration of hand function in neuromuscular disorders, and biomechanical modeling of muscle function. Scientific Awards and Recognition: Multiple awards from the American Society for Surgery of the Hand including the Andrew J. Weiland Medal for Outstanding Research (2013) Richard A. Berger Excellence in Teaching Award (2020) Julian Brunner Award for Best Poster (2023) Best Papers Session award for brachial plexus research (2024) Recipient of NIH R01 funding for nerve regeneration research Dr. Shin has received consistent recognition for both his research contributions and teaching excellence, with numerous awards spanning clinical innovation, basic science research, and educational leadership. His laboratory maintains an active collaboration with Radboud University Medical Center in the Netherlands, reflecting his international impact in the field of nerve regeneration and reconstructive surgery.

Fabio Simoesمشاهده پروفایل

استادیار

• Acute myeloid leukaemia (AML)
• Bone marrow microenvironment
• Molecular pathology
• +۴ مورد دیگر

Dr. Fabio Simoes is an Assistant Professor in Cancer Research within the Clinical and Experimental Medicine department at Brighton and Sussex Medical School (BSMS), part of the University of Sussex. With over a decade of experience in disease modeling and molecular biology, he leads a research laboratory focused on acute myeloid leukaemia (AML) and the bone marrow microenvironment. Dr. Simoes completed his PhD at BSMS in 2017, following earlier degrees including an MSc in Neuroscience from King's College London and a BSc in Biomedical Sciences from Queen Mary University of London. His research journey began with motor neuron disease studies, progressed through osteoarthritis research, and has now focused on hematological malignancies. His current research examines how AML cells remodel the bone marrow microenvironment to promote disease progression and therapy resistance. By employing in vitro co-culture systems, RNA sequencing, and translational in vivo models, his work aims to identify novel therapeutic targets such as CD44 and Focal Adhesion Kinase to overcome cell adhesion-mediated drug resistance. Analysis of his recent publications reveals a strong focus on tumor microenvironment interactions, computational modeling of blood cancers, and translational approaches to improve treatment outcomes. Dr. Simoes currently holds an active research grant from the SUSSEX CANCER FUND FOR TREATMENT AND RESEARCH (2024-2028) focused on characterizing and targeting chemo-resistant AML cells. His laboratory team includes researchers like Sophie Vause and Aleksandra, who joined in late 2024. As an educator, Dr. Simoes serves as an Academic Skills Tutor, delivers Molecular Cell Biology tutorials, and has designed advanced neuroscience workshops for postgraduate students. He supervises multiple research projects and holds Associate Fellowship of the Higher Education Academy. His laboratory, accessible through www.simoes.science, represents a growing research group dedicated to advancing our understanding of AML biology and developing novel therapeutic approaches that target the tumor microenvironment.